Diabetes Health Center
Type 1 Diabetes: Living With Complications - References
Citations
Tabibiazar R, Edelman S (2003). Silent ischemia in people with diabetes: A condition that must be heard. Clinical Diabetes, 21(1):5-9.
American Diabetes Association (2004). Retinopathy in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S84-S87.
American Diabetes Association (2004). Nephropathy in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S79-S83.
American Diabetes Association (2008). All About Diabetes. Available online: http://www.diabetes.org/about-diabetes.jsp.
American Diabetes Association (2008). Standards of medical care in diabetes. Clinical Practice Recommendations 2008. Diabetes Care, 31(Suppl 1): S12-S54.
American Diabetes Association (2004). Hypertension management in adults with diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S65-S67.
American Diabetes Association (2004). Preventive foot care in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S63-S64.
Nathan DM (2003). Isolated pancreas transplantation for type 1 diabetes. JAMA, 290(21): 2861-2863.
American Diabetes Association (2004). Smoking and diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S74-S75.
Sigal R, et al. (2006). Prevention of cardiovascular events in diabetes, search date November 2004. Online version of Clinical Evidence. Also available online: http://www.clinicalevidence.com.
Sutherland DE, et al. (2001). Lessons learned from more than 1,000 pancreas transplants at a single institution. Annals of Surgery, 233(4): 463-501.
Other Works Consulted
ACE Inhibitors in Diabetic Nephropathy Trialist Group (2001). Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? Annals of Internal Medicine, 134(5): 370-379.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002). Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA, 287(19): 2563-2569.
Gerstein HC, et al. (2001). Cardiovascular disease. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 488-514. Hamilton, ON: BC Decker.
Goguen JM, Leiter LA (2001). Alternative therapy: The role of selected minerals, vitamins, fiber, and herbs in treating hyperglycemia. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 295-322. Hamilton, ON: BC Decker.
Harvey DT (2001). Classification and risk of musculoskeletal impairment associated with diabetes. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 523-530. Hamilton, ON: BC Decker.
Heaton JPW, et al. (2001). Erectile dysfunction. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 531-544. Hamilton, ON: BC Decker.
Hunt D (2008). Diabetes: Foot ulcers and amputations, search date September 2006. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.
Ludwig DS (2002). The glycemic index: Physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA, 287(18): 2414-2423.
Mendrinos E, et al. (2008). Diabetic nephropathy, search date March 2007. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.
Molitch ME, Genuth S (2006). Complications of diabetes mellitus. In DC Dale, DD Federman, eds., ACP Medicine, section 9, chap. 3. New York: WebMD.
Patel J (2008). Diabetes: Managing dyslipidaemia, search date June 2007. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.
Pickup J, Keen H (2002). Continuous subcutaneous insulin infusion at 25 years. Diabetes Care, 25(30): 593-598.
Shlipak M (2008). Diabetic nephropathy, search date November 2006. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.
Steele AW (2001). Kidney disease. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 429-465. Hamilton, ON: BC Decker.
Vijan S, (2008). Diabetes: Treating hypertension, search date February 2007. Online version of BMJ Clinical Evidence. Also available online: http://www.clinicalevidence.com.
WebMD Medical Reference from Healthwise
Type 1 Diabetes: Living With Complications Topics
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Please see UROXATRAL full prescribing information.
Vinegar is in everything from coleslaw to pickles. What if you could actually use it to help prevent disease?
